Dysregulation of ECM remodelling via elevated TGFβ ligands and inflammation results in excess collagen deposition, which may create a physical barrier that could impair the uptake of glucose and the binding of insulin to the receptor, contributing to the development of insulin resistance (29–32). The gene discussed is TGFB1; the disease is Insulin resistance.